Back to search
FDAFDA · Food and drugs·Recall number D-1329-2022

Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4

Published August 17, 2022 · Recall initiated: July 20, 2022

Summary

FDA records drug Class III recall D-1329-2022, published August 17, 2022 and initiated July 20, 2022. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 8328 bottles; Lot: Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength

What to do

Voluntary: Firm initiated · Letter

Get an email if LAMOTRIGINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LAMOTRIGINE
Manufacturer
AVKARE Inc.
Distributor
Nationwide within the United States
UPC
0342291368606
Lot
Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4 recalled?

Yes. FDA published recall D-1329-2022 on August 17, 2022. Reported hazard: Labeling: Label Error on Declared Strength

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0342291368606.